-
-
-
-
-
-
-
Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation
-
-
-
-
-
-
-
Sangamo Therapeutics (SGMO) Tops Q4 EPS by 3c, Revenues Beat
-
-
-
-
-
-
-
Sangamo and TxCell Announce the Completion of the Acquisition by Sangamo of Majority of TxCell Ordinary Shares
-
-
-
-
-
-
-
Pre-Open Movers 11/15: (SORL) (CARG) (BCEI) Higher; (ACOR) (VERI) (MTSI) Lower (more...)
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 9/23: (RWLK) (TKMR) (SLXP) Higher; (ASNA) (KMX) (AVNR) Lower (more...)
-
-
-
-
1,154,949 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

